Table 1.
Skin samples | Microscopic lesions | Detection of Leishmania | ||
---|---|---|---|---|
HE | IHQ | qPCR | ||
Normal-looking skin (n = 25) | 14/25 (56.0 %) | 5/25 (20%) | 8/25 (32.0%) | 18/25 (72.0%) |
Stage I (n = 11) | 3/11 (27.3%)a,b | 0/11 (0%)c | 1/11 (9.1%)d | 5/11 (45.5%)e |
Stage II-III (n = 14) | 11/14 (78.6%)b | 5/14 (35.7%)c | 7/14 (50.0%)d | 13/14 (92.9%)e |
Clinically-lesioned skin (n = 25) | 25/25 (100%) | 11/25 (44.0%) | 23/25 (92.0%) | 25/25 (100%) |
Stage I (n = 11) | 11/11 (100%)a | 1/11 (9.1%)f | 9/11 (81.8%) | 11/11 (100%) |
Stage II-III (n = 14) | 14/14 (100%) | 10/14 (71.4%)f | 14/14 (100%) | 14/14 (100%) |
Abbreviations: HE haematoxylin and eosin stained sections, IHC Leishmania immunohistochemistry, qPCR quantitative PCR
aMcNemar's test: P = 0.008
bFisher’s exact test: P = 0.0172
cFisher’s exact test: P = 0.0464
dFisher’s exact test: P = 0.0421
eFisher’s exact test: P = 0.0068
fFisher’s exact test: P = 0.0037